• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number ECH460045J
Device Problem Peeled/Delaminated (1454)
Patient Problem Renal Failure (2041)
Event Date 02/27/2020
Event Type  Injury  
Manufacturer Narrative
The investigation is ongoing.
 
Event Description
The following was reported to gore: on (b)(6) 2019, the patient presented for shunt construction in the arm because of renal failure.A gore® acuseal vascular graft was implanted.Approximately 2-3 week post implant, the first puncture was performed.On (b)(6) 2020, ultrasound scan revealed irregularities within the graft (details are unknown).On (b)(6) 2020, pta ballooning was performed.On (b)(6) 2020, ultrasound scan revealed a flap-like part in the venous side of the acuseal vascular graft.The physician suspected delamination of the graft.On the arterial side of the acuseal vascular graft, traces of wall puncture were observed.The physician suspected thrombus.A part of the device was removed by the physician.
 
Manufacturer Narrative
Corrected date: h6.Results code 1 additional manufacturer narrative: review of the manufacturing records verified that the lot met release requirements.The investigation is ongoing.
 
Manufacturer Narrative
Additional manufacturing narrative: c1.Name (#1) - cbas® heparin surface; manufacturer/compounder: w.L.Gore & associates, inc.Lot #6365351pp007.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
Corrected data: h6.- method code 2; h6.- results code 2; h6.- conclusions code 1; additional manufacturer narrative: examination of the returned device revealed the following: all material findings (i.E., radial film disruptions, cannulation holes, forceps marks) appear to be consistent with intervention during a surgical procedure (i.E., tunneling, cannulation, and grasping/pulling).There was no ¿flaplike structure¿ observed in the lumen during post-digestion analysis.The graft layers were intact and material delamination was not observed on any device fragment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9879034
MDR Text Key189484377
Report Number2017233-2020-00213
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 08/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/10/2022
Device Catalogue NumberECH460045J
Device Lot Number6365351PP007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/17/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/25/2020
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received03/31/2020
07/31/2020
08/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-